Literature DB >> 20007578

Novel role for aldose reductase in mediating acute inflammatory responses in the lung.

Thyyar M Ravindranath1, Phyllus Y Mong, Radha Ananthakrishnan, Qing Li, Nosirudeen Quadri, Ann Marie Schmidt, Ravichandran Ramasamy, Qin Wang.   

Abstract

Exaggerated inflammatory responses and the resultant increases in alveolar-capillary permeability underlie the pathogenesis of acute lung injury during sepsis. This study examined the functions of aldose reductase (AR) in mediating acute lung inflammation. Transgenic mice expressing human AR (ARTg) were used to study the functions of AR since mice have low intrinsic AR activity. In a mild cecal ligation and puncture model, ARTg mice demonstrated an enhanced AR activity and a greater inflammatory response as evaluated by circulating cytokine levels, neutrophil accumulation in the lungs, and activation of Rho kinase in lung endothelial cells (ECs). Compared with WT lung cells, ARTg lung cells produced more IL-6 and showed augmented JNK activation in response to LPS stimulation ex vivo. In human neutrophils, AR activity was required for fMLP-included CD11b activation and up-regulation, respiratory burst, and shape changes. In human pulmonary microvascular ECs, AR activity was required for TNF-alpha-induced activation of the Rho kinase/MKK4/JNK pathway and IL-6 production, but not p38 activation or ICAM-1 expression. Importantly, AR activity in both human neutrophils and ECs was required for neutrophil adhesion to TNF-alpha-stimulated ECs. These data demonstrate a novel role for AR in regulating the signaling pathways leading to neutrophil-EC adhesion during acute lung inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007578      PMCID: PMC3144631          DOI: 10.4049/jimmunol.0900720

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Elevated glucose concentrations promote receptor-independent activation of adherent human neutrophils: an experimental and computational approach.

Authors:  Ursula Kummer; Jürgen Zobeley; Jens Christian Brasen; Ryan Fahmy; Andrei L Kindzelskii; Aaron R Petty; Andrea J Clark; Howard R Petty
Journal:  Biophys J       Date:  2007-01-19       Impact factor: 4.033

2.  Cecal ligation and puncture with total parenteral nutrition: a clinically relevant model of the metabolic, hormonal, and inflammatory dysfunction associated with critical illness.

Authors:  Josef G Heuer; Dianna L Bailey; Ganesh R Sharma; Tonghai Zhang; Chunjin Ding; Amy Ford; Eddie J Stephens; Kimberly C Holmes; Renee L Grubbs; Kelly A Fynboe; Yun-Fei Chen; Joseph A Jakubowski
Journal:  J Surg Res       Date:  2004-10       Impact factor: 2.192

3.  Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta.

Authors:  Yuk Yin Cheung; So Youn Kim; Wai Han Yiu; Chi-Jiunn Pan; Hyun-Sik Jun; Robert A Ruef; Eric J Lee; Heiner Westphal; Brian C Mansfield; Janice Y Chou
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

4.  Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha.

Authors:  F Bussolino; G Camussi; C Baglioni
Journal:  J Biol Chem       Date:  1988-08-25       Impact factor: 5.157

5.  Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia. Role of oxidative stress, reduced NO, and enhanced PGH(2)/TXA(2) mediation.

Authors:  Erika Toth; Anita Racz; Janos Toth; Pawel M Kaminski; Michael S Wolin; Zsolt Bagi; Akos Koller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-09-14       Impact factor: 4.733

6.  Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model.

Authors:  C C Baker; I H Chaudry; H O Gaines; A E Baue
Journal:  Surgery       Date:  1983-08       Impact factor: 3.982

7.  NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death.

Authors:  Sachiko Sakon; Xin Xue; Mutsuhiro Takekawa; Tomonari Sasazuki; Tatsuma Okazaki; Yuko Kojima; Jian-Hu Piao; Hideo Yagita; Ko Okumura; Takahiro Doi; Hiroyasu Nakano
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

8.  Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin.

Authors:  S M Prescott; G A Zimmerman; T M McIntyre
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Activation of Rho kinase by TNF-alpha is required for JNK activation in human pulmonary microvascular endothelial cells.

Authors:  Phyllus Y Mong; Christian Petrulio; Howard L Kaufman; Qin Wang
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

10.  High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group.

Authors:  T Calandra; J Gerain; D Heumann; J D Baumgartner; M P Glauser
Journal:  Am J Med       Date:  1991-07       Impact factor: 4.965

View more
  18 in total

1.  Involvement of the Rho kinases in mediating sepsis.

Authors:  T C Tai
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

Review 2.  A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases.

Authors:  Saumya Pandey; Satish K Srivastava; Kota V Ramana
Journal:  Expert Opin Investig Drugs       Date:  2012-01-28       Impact factor: 6.206

Review 3.  Targeting aldose reductase for the treatment of cancer.

Authors:  Ravinder Tammali; Satish K Srivastava; Kota V Ramana
Journal:  Curr Cancer Drug Targets       Date:  2011-06       Impact factor: 3.428

4.  Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.

Authors:  Umesh C S Yadav; Mohammed Shoeb; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

5.  Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats.

Authors:  Umesh C S Yadav; Mohammad Shoeb; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-11       Impact factor: 4.799

6.  Aldose reductase (AKR1B) deficiency promotes phagocytosis in bone marrow derived mouse macrophages.

Authors:  Mahavir Singh; Aniruddh Kapoor; James McCracken; Bradford Hill; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2017-01-19       Impact factor: 5.192

7.  MicroRNA-92a negatively regulates Toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase.

Authors:  Lihua Lai; Yinjing Song; Yang Liu; Qingyun Chen; Quan Han; Weilin Chen; Ting Pan; Yuanyuan Zhang; Xuetao Cao; Qingqing Wang
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

8.  Aldose reductase inhibition prevents metaplasia of airway epithelial cells.

Authors:  Umesh C S Yadav; Leopoldo Aguilera-Aguirre; Kota V Ramana; Istvan Boldogh; Satish K Srivastava
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

9.  Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat.

Authors:  Kazunori Takahashi; Hiroki Mizukami; Kosuke Kamata; Wataru Inaba; Noriaki Kato; Chihiro Hibi; Soroku Yagihashi
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

10.  Aldose reductase inhibition prevents allergic airway remodeling through PI3K/AKT/GSK3β pathway in mice.

Authors:  Umesh C S Yadav; Amarjit S Naura; Leopoldo Aguilera-Aguirre; Istvan Boldogh; Hamid A Boulares; William J Calhoun; Kota V Ramana; Satish K Srivastava
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.